What You Should Know:
– Serve You Rx announced today the inclusion of two newly approved biosimilars to Stelara® (ustekinumab) – Otulfi™ (ustekinumab-aauz) and Yesintek™ (ustekinumab-face) – to its Biosimilar Advantage Formulary. This move is…
Continue Reading
Josh Canavan, Head of Pharmacy at RazorMetrics
Millions of Americans are currently facing a difficult choice: either pay for expensive biologic medications or ration doses to afford basic needs. Cost-related nonadherence (CRN) is where patients…
Continue Reading
Dr. Minh Huynh, Medical Director at NantHealth
Eliminating healthcare inequities requires addressing the underlying social and economic factors that contribute to these disparities and ensuring that all individuals have equal access to high-quality healthcare services,…
Continue Reading
In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient summary of everything that happened so you can stay informed, educated, and engaged with the Digital Health world around you.
Continue Reading
A whole new way to develop medicines has grown up around biotherapeutics, of which the best-known are a subset called biosimilars. Over the past ten years, a class of biotherapeutics called cell and gene…
Continue Reading
